HC Advisors LLC acquired a new position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,243 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. Other institutional investors and hedge […]
Cytokinetics (NASDAQ:CYTK – Get Free Report) issued its earnings results on Tuesday. The biopharmaceutical company reported ($1.38) earnings per share for the quarter, missing the consensus estimate of ($1.03) by ($0.35), Briefing.com reports. The company had revenue of $1.70 million for the quarter, compared to analysts’ expectations of $7.62 million. The firm’s quarterly revenue was […]
Moody Aldrich Partners LLC increased its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 5.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 94,448 shares of the biopharmaceutical company’s stock after purchasing an additional 5,172 shares during […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) was the target of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 13,750,000 shares, a decrease of 8.8% from the December 31st total of 15,080,000 shares. Currently, 14.7% of the company’s stock are short sold. Based […]